OpenCell Technologies, an R&D-stage biomedical venture, has appointed Kevin Gutshall as chief executive officer to lead efforts to translate and commercialize its core technology platform, POROS. Kevin joins the company from MilliporeSigma where he served as director of life science business development and M&A focusing on the cell and gene therapy business unit.    OpenCell was established based on technology developed at the Georgia Institute of Technology, which has broad ap...